Skip to main content

AGC Pharma Chemicals Europe has completed the investment of the in-house micronization facility which will broaden its service level for customers.

With a feed capacity of 30kg/h (max 50kg/h), the state-of-the-art unit has been designed to handle a wide range of API including HAPI compounds with OEB 4 (OEL band 1-10µg/m3).

The micronizer equipment is a Hosokawa Alpine Multi-Mill, with a dual system which enables wider applications.

The project denominated “Implementation of a new micronization technology for the expansion and diversification of the site capacity” (file nº: ACE002/20/000031) was partially financed by funds from ACCIÓ – Catalonia Trade & Investment of the Generalitat de Catalunya.

The new capability will provide higher flexibility and will offer our customers a complete process integration for their projects.

Contact us for more information.

Latest News

AGC PharmaEvents & ConventionsAGC Pharma Chemicals to Attend BOS Basel 2026
4th June 2026

AGC Pharma Chemicals to Attend BOS Basel 2026

Meet AGC Pharma Chemicals at CPHI Frankfurt 2025, Booth 6.0B44. Discover how we deliver top pharma quality through our CDMO services for APIs and HPAPIs.
AGC PharmaEvents & ConventionsAGC Pharma Chemicals to Attend BIO International Convention 2026
4th June 2026

AGC Pharma Chemicals to Attend BIO International Convention 2026

Meet AGC Pharma Chemicals at CPHI Frankfurt 2025, Booth 6.0B44. Discover how we deliver top pharma quality through our CDMO services for APIs and HPAPIs.
AGC PharmaAll of ArticlesCDMO ProcessesCDMO TechnologyThe Power of Micronization in Small Molecule APIs
2nd June 2026

The Power of Micronization in Small Molecule APIs

Meet AGC Pharma Chemicals at CPHI Frankfurt 2025, Booth 6.0B44. Discover how we deliver top pharma quality through our CDMO services for APIs and HPAPIs.